Biotech Business Week back issues from October 2003:
Engineered antibodies may expedite development of therapeutic oncology agents.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Panacea Pharmaceuticals, Inc., has extended and expanded its collaborative research agreement with researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, covering the development of all-human, ultra-affinity, ...
Positive phase III results for bicifadine, a novel, non-narcotic analgesic, announced.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) announced positive efficacy and safety results for its phase III clinical trial investigating its novel, non-narcotic analgesic, bicifadine, in the treatment of moderate to severe post-surgical dental pain. ...
Patient enrollment completed in cryoblation study.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- CryoCor, Inc., a development stage medical technology company, announced the completion of U.S. patient enrollment of the first phase of the feasibility trial for paroxysmal atrial fibrillation and the initiation of additional enrollment in the ...
Merck enters alliance to apply RNA interference for human therapeutics.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Merck & Co., Inc., (MRK) and Alnylam Holding Co., an RNA interference (RNAi) company, announced that they have entered into a multiyear collaboration to develop RNAi-based technology and therapeutics. This strategic alliance represents, ...
Report: Lack of IPOs stifle early-stage healthcare investments.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The lack of an IPO market isn't just putting pressure on later-stage healthcare companies. Early-stage ventures are suffering too, according to a report in the September issue of The Venture Capital Analyst-Health Care Edition. ...
Myozyme development program expanded.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced the launch of several initiatives designed to support the rapid development and approval of Myozyme recombinant human acid alpha-glucosidase and provide greater access to the enzyme for patients in need during the ...
Promising results reported on new protease activated therapy.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Dendreon Corporation (DNDN) announced that it will present data on a lead compound from its new Protease Activated Therapy (PACT) therapeutic platform. In preclinical testing to date, the compound, CVS 10290, has demonstrated a ...
Incyte enters licensing agreement for a phase II HIV drug.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Incyte Corp. (INCY) and Pharmasset, Ltd., announced that they have entered into a collaborative licensing agreement to develop and commercialize the antiretroviral drug Reverset, also known as RVT, D-D4FC, or DPC-817, which is currently in phase ...
FDA clears BLU-U Blue Light Photodynamic Therapy Illuminator.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DUSA Pharmaceuticals, Inc., (DUSA) reported that on September 9, 2003, it received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for the BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170, which allows DUSA ...
Innovative Medical enters partnership to develop, market Axenohl-based products.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Innovative Medical Services (PURE) has signed an agreement with Therapeutics, Inc., a drug development company based in La Jolla, California, for the development and commercialization of U.S. Food and Drug Administration (FDA) regulated ...
Amelioration of asthma symptoms reported with anti-C5 therapy.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) is reporting that anti-C5 monoclonal antibody therapy blocked the development of bronchial inflammation and reduced airway hyperresponsiveness in preclinical models of severe allergic asthma. The ...
Asthma attacks at school are disruptive to routine, under-diagnosed.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- According to a national sample of members surveyed from the National Association of School Nurses, asthma is more disruptive of school routines than any other chronic condition and has a significant impact on absenteeism and many school staff may ...
NIAID grant to awarded to develop phenotype microarray technology.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Biolog, Inc., announced that it has received a multi-year grant of $2.28 million from the National Institute of Allergy and Infectious Diseases (NIAID). This grant will fund additional development of advanced detection and identification ...
Study findings suggest strategy for regeneration of tissues in damaged brains.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS) announced that the current issue of the scientific journal Neuron contains a report demonstrating that the Hedgehog signaling pathway is required for the formation and maintenance of brain progenitor cells. These ...
GeneMax Corp. announces agreement for the production of TAP cancer vaccine.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced an amended contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP genes (transporters associated with antigen ...
Epimmune earns milestone payment under cancer epitope license.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has earned and received a milestone payment from Anosys, Inc., as a result of Anosys' filing of an IND for a product incorporating Epimmune technology under a license granted to Anosys in August 2001. ...
FDA grants approval to start atrial fibrillation study.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., (CYT), announced that is has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) to initiate a study to treat atrial fibrillation (AF). The ...
Clinical update provided on BST-CarGel.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioSyntech (BSYI) recently announced the treatment of its chairman, Serge Savard with BST-CarGel, under Health Canada's Special Access Programme for medical devices. Savard has fully recovered and is undergoing a specialized ...
Research aims to understand how mistakes in DNA replication lead to disease.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Studies at the University of Houston (UH) are shedding light on the mechanisms our bodies use to recognize and repair mistakes in our genetic code, mistakes that, left unchecked, could lead to cancer. DNA is the body's blueprint found in ...
Continuous labor support offers benefits to mothers, babies.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A new comprehensive study describing the experiences of nearly 13,000 women has found that women who receive supportive care from a companion throughout labor are more likely than women without such care to avoid cesarean birth and other major ...
Agreements signed for cardiac safety monitoring, information distribution services.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT, ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has received agreements for more than $1.4 million in cardiac safety monitoring and services from ...
Alliance with CryoVascular Systems for cardiology device technology.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that it has entered into a series of agreements with CryoVascular Systems, Inc., a privately held company located in Los Gatos, California. CryoVascular has received U.S. Food and Drug ...
Oral drug delivery research alliance signed.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) has entered into a research collaboration in oral drug delivery with the Celltech Group plc (CLL, CCH), of Slough, England. The goal of the collaboration is to develop oral drug delivery options for ...
Generic version of Paxil launched.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Apotex Corp. announced that it has launched paroxetine hydrochloride tablets, 10 mg, 20 mg, 30 mg, and 40 mg. The U.S. Food and Drug Administration has determined that Apotex' paroxetine tablets are therapeutically equivalent to ...
Trial shows Probactrix is effective for treating diarrhea caused by antibiotics.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The BioBalance Corp., a wholly owned subsidiary of New York Health Care (BBAL), released the results of a randomized clinical study in which a formulation containing its proprietary biotherapeutic agent, Probactrix, appeared to rapidly and ...
Mexican distributor granted exclusive rights for Microcyn 60.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Oculus Technologies of Mexico, S.A., de C.V., a subsidiary of Oculus Innovative Sciences, announced the finalization of an exclusive agreement with Quimica Pasteur, S. De RL., for distribution of Oculus's Microcyn 60 disinfectant and antiseptic in ...
AERx pain management system study data published.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers, led by scientists at Aradigm Corporation, (ARDM) published results of a clinical study involving the AERx Pain Management System in the September 2003 issue of the journal Anesthesiology. Results from the clinical study ...
$2M grant awarded for development of drug research software.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Targacept, Inc., has been awarded a grant from the National Institute of Standards and Technology (NIST) through its Advanced Technology Program (ATP) that will provide approximately $2 million over a 3-year period. The award will help ...
New information management system available for pharma, biotech firms.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc., (PCOP), announced the release of its latest solutions for chemical and biological information management: Accord Enterprise Informatics and DS Accord for Excel Enterprise. Accord ...
Device company gets NIH grant for neurological surgery technology.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Astro-Med, Inc., (ALOT) announced that it has received an SBIR research grant of $107,000 from the U.S. National Institutes of Health for the purpose of developing a computer controlled switching stimulation/amplifier system. The ...
Acquisition of pharmaceutical company completed.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ampersand Ventures, a venture capital firm with approximately $600 million under management in four target sectors, including life sciences, announced that ArQule, Inc., has completed its acquisition of Cyclis Pharmaceuticals, one of Ampersand's ...
American Stock Exchange lists oncology company's stock.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (AMEX) listed the common stock of Bioenvision, Inc., under the ticker symbol BIV. Bioenvision primarily focuses on the acquisition, development, and distribution of compounds and technologies for the treatment ...
Angiotech to change fiscal year end financials to calendar year.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI; ANP) announced that it intends to change its fiscal year end from September 30 to December 31, effective as of December 31, 2003. This step is being taken to synchronize the fiscal reporting period ...
Dialysis company calls 7% convertible notes, authorizes share repurchase.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DaVita, Inc., (DVA) announced that it is calling for redemption the remainder of its 7% convertible subordinated notes due 2009. The aggregate principal amount outstanding of the Notes is $145 million. The CUSIP numbers for the Notes are ...
Medical device company raises $13.6M in second round financing.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- AngioLink Corporation announced that it has raised $13.6 million in preferred equity financing from new and existing investors. JHK Investments, LLC, BioVentures Investors, and IDP Investments led the financing, and Boston Equity ...
Pharmaceutical company's stock listed on AMEX.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (AMEX) listed the common stock of Pro-Pharmaceuticals, Inc. (PRW). Pro-Pharmaceuticals, Inc., is a drug development company commercializing a new generation of anti-cancer treatments using carbohydrate ...
Revised financial expectations reported by pharmaceutical company.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO), a leading global specialty pharmaceutical company, announced revised expectations for the second half and full year 2003. The company currently expects third quarter 2003 diluted earnings per share in the range of ...
Skin substitute manufacturer emerges from Chapter 11 protection.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Organogenesis Inc. announced the completion of its court-approved reorganization plan, allowing the company to emerge from Chapter 11 protection and continue manufacturing and supplying Apligraf, its bilayered skin substitute approved to heal ...
Topical drug company announces $3.25 million private placement.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- MacroChem Corp. (MCHM) announced that it has raised approximately $3.25 million in gross proceeds from a private placement of its securities, primarily to institutional investors. MacroChem is a specialty pharmaceutical company ...
Venture financing round completed with Emerging Technology Partners.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC, announced the completion of a round of venture financing with the Emerging Technology Partners of Rockville, Maryland. In the transaction, the company also acquired adenosine screening technology from Aptus ...
$4M financing advances antithrombotic agent into clinical development.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Targeted Molecules Corp. (TMC) announced the completion of a $4 million financing by a group of investors that will be used to advance TMC's lead compound, TMC-2001, into clinical development and to continue the preclinical development of several ...
$6M in funds helps biotech company develop psychiatric disease treatments.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Psychiatric Genomics, Inc., a company utilizing expression analysis of human tissues to develop innovative small molecule drugs to treat mental health disorders, announced closing on a $6 million financing commitment with The Stanley Medical ...
GSK makes announcement regarding launch of generic paroxetine hydrochloride.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) confirmed that a generic form of paroxetine hydrochloride was launched by Apotex Corp. on September 8, 2003, triggering GSK's license agreement with Par Pharmaceutical, Inc. Under the terms of the agreement ...
New bioconsumable kits aid in genetic variation discovery and detection.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Transgenomic Inc. (TBIO) has launched the Surveyor line of bioconsumable kits for use in genetic variation discovery and detection, extending the capabilities of the company's Wave system instrument platform, as well as offering ...
HIV-1 antibody tests approved for distribution in the Republic of Uganda.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (CYPT), the developer and marketer of the only two U.S. Food and Drug Administration (FDA) approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot ...
Genetically enhanced bacteria may prevent HIV infections in women.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers at the Stanford University School of Medicine have found in laboratory experiments that bacteria that naturally live in the body can be genetically enhanced for potent antiviral activity, potentially preventing HIV infections in women. ...
Japanese government expands use of automated external defibrillators.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB) announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has for the first time approved the use of automated external defibrillators (AEDs) by non-medical persons. The new law represents a ...
Acetaminophen may be best for patients on cardioprotective aspirin therapy.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Heart specialists say acetaminophen, the medicine in Tylenol, may be the best choice over-the-counter pain reliever for the millions of Americans taking aspirin to protect against cardiovascular disease. New findings in Circulation, a ...
FDA clearance granted for new D-10 Hemoglobin testing system.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIO.B) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its D-10 Hemoglobin A1c system that includes both the D-10 instrument and Hemoglobin A1c test kit. This compact, ...
Agreement signed with Baxter for Advate distribution.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Curative Health Services, Inc., (CURE) announced that it has signed a multiyear supply agreement with Baxter Healthcare Corporation for Advate (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method) rAHF-PFM for the prevention and control ...
U.S. commercial availability of Advate announced.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Following its recent U.S. launch of Advate, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method, (rAHF-PFM), Baxter Healthcare Corporation (BAX) announced that it has signed non-exclusive multiyear agreements with several leading U.S ....
Clinical trials of Coagulin-B to resume.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., (AVGN) announced that it has received approval to proceed with its phase I clinical trial of Coagulin-B for the treatment of hemophilia B from both the U.S. Food and Drug Administration (FDA) and the Institutional Review Boards (IRB) ...
Hepatitis vaccine approved for sale in Argentina.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced the Argentinean approval of Supervax, Berna Biotech's prophylactic vaccine containing Corixa's synthetic RC-529 adjuvant, for the prevention of Hepatitis B infection. Developed by Berna Biotech, the ...
Final FDA approval received for generic Glucotrol XL 5mg tablets.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) confirmed that Watson Pharmaceuticals, Inc., (WPI), had received approval on its Abbreviated New Drug Application (ANDA) for 5 mg glipizide extended-release tablets from the U.S. Food and Drug Administration (FDA). ...
New drug application submitted for cinacalcet HCl.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) filed a new drug application (NDA) with the U.S. Food & Drug Administration for cinacalcet HCl, a first-in-class oral calcimimetic agent, licensed from NPS Pharmaceuticals, Inc., currently being investigated for the treatment of ...
Benicar HCT now available in U.S.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Sankyo Pharma, Inc., and Forest Laboratories, Inc., (FRX) announced that Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) is now available via prescription in the United States. Benicar HCT combines the angiotensin II receptor ...
Changes in IV formula can reverse neurological problems in bowel failure patients.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Intravenous feedings may do well to provide patients with small bowel failure their required daily nutrition, but its long-term use can cause their liver to fail and Parkinson-like neurological symptoms, particularly in those patients who do ...
Corixa Corp. signs research, development, and license agreement.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- InNexus Biotechnology, Inc., (IXS), a monoclonal antibody-development company, and Corixa Corp. (CRXA), a developer of immunotherapeutic products, announced that the companies have entered into an antibody research, development, and license ...
Adults with asthma fail to follow flu vaccine guidelines.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Adults with asthma are considered a high risk group for developing complications after contracting the influenza virus, yet the majority of adults with asthma does not receive an annual influenza vaccination, said a study published in the September ...
Alliance to bring added automation to Oracle clinical users.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioPharm Systems, Inc., announced a partnership with Quovadx (QVDX) to introduce a new software and services offering that enhances the communications capabilities and automates key functions of Oracle Clinical, the industry leading Clinical Data ...
Diabetes care moves online.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- ConnectiCare and Medem announced the launch of a new service that will, for the first time, allow insured patients with diabetes to send their glucose readings to their own doctors securely via the Internet. This new service will allow ...
Collaborative effort to develop inhaled insulin.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) and QDose, a joint venture between MicroDose Technologies, Inc., and Quadrant Drug Delivery, Ltd., announced that the companies have entered into a licensing agreement for the QDose inhaled insulin product. ...
NIH provides grant for oral insulin development.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has been awarded a $100,000 Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH) to support the company's development of formulations for the oral ...
Label language finalized for Sucanon release in Mexico.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIOHF.OB; BIO.V), reported that the finalized language for the Sucanon label has been submitted to Mexican regulators. "In the process of finalizing label language, the Board of Health ...
Partnership to hold investments in two medical device companies.
Oct 06, 2003 ... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- ev3, LLC, a new investment partnership controlled by Warburg Pincus, the global private equity firm, announced that its holdings now include 100% of ev3, Inc., and approximately 70% of Micro Therapeutics, Inc. ev3, Inc., a privately held ...